Cold Start Therapeutics enables rational, target-first hit discovery for yet-to-be liganded targets through our computational biophysics platform's ability to reveal previously invisible pocket motion. Our technology has uniquely enabled our diverse pipeline that includes a pan-mutant, wild-type sparing, beta-catenin molecule glue degrader program, Myc molecular glue degrader program, and a GLP-1R, GIPR, GCGR (triple G) small molecule agonist program.
Company Details
- Employees
- 5
- Address
- San Diego, Ca 92126, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.coldstart-tx.com/
- HQ
- San Diego, CA
Cold Start Therapeutics Questions
Cold Start Therapeutics's website is https://www.coldstart-tx.com/
Cold Start Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cold-start-therapeutics
Cold Start Therapeutics has
5 employees.
View email and phone details for 5
employees at Cold Start Therapeutics.
Cold Start Therapeutics's industry is
Biotechnology Research
Cold Start Therapeutics's top competitors are
Ausperbio,
Samsara Biocapital,
Srt Therapeutics Inc.,
Stylus Medicine,
Agenus,
Kincell Bio,
Aditum Bio,
Auron Therapeutics, Inc.,
Vima Therapeutics,
Grin Therapeutics, Inc..
Cold Start Therapeutics's categories are Biotechnology Research
